Drug – bio-affecting and body treating compositions – Plural fermentates of different origin
Patent
1978-09-01
1980-12-23
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Plural fermentates of different origin
2602452R, C07D27760, A61K 31425, A61K 3143
Patent
active
042410509
ABSTRACT:
(3S, 5R)-Penam-3-carboxylic acid 1,1-dioxide, optionally having a methyl group at the 2-position, and esters thereof readily hydrolyzable in vivo, are useful for enhancing the effectiveness of several beta-lactam antibiotics against many beta-lactamase producing bacteria.
REFERENCES:
patent: 3197466 (1965-07-01), Chow et al.
patent: 3536698 (1970-10-01), Chauvette et al.
Recent Advances in the Chemistry of .beta.-Lactam Antibiotics, edited by J. Elks, Special Publication No. 28, pp. 304-313, Burlington House, (1977), London.
Guddaz et al., Tetrahedron Letters, No. 9, 381, (1962).
Harrison et al., Jour. Chem. Soc., (London), Perkin I, 1772, (1976).
Antibiotki, 13, 155-158, (1968).
Hoogmartens et al., Jour. of Med. Chem., 17, 389, (1974).
Claes et al., European Jour. of Med. Chem. Chimica Therapeutica, 10, 573, (1975).
Pfizer Inc.
Rizzo Nicholas S.
LandOfFree
Penam 1,1-dioxides as beta-lactamase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Penam 1,1-dioxides as beta-lactamase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Penam 1,1-dioxides as beta-lactamase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2242476